首页> 外国专利> 3- AND 5-SUBSTITUTED 1,2,3,4-OXATRIAZOLE-5-IMINE COMPOUNDS, METHOD FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THE USE OF THE COMPOUNDS FOR THE PRODUCTION OF MEDICAMENTS

3- AND 5-SUBSTITUTED 1,2,3,4-OXATRIAZOLE-5-IMINE COMPOUNDS, METHOD FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THE USE OF THE COMPOUNDS FOR THE PRODUCTION OF MEDICAMENTS

机译:3-和5-取代的1,2,3,4-恶三唑-5-亚胺化合物,其制备方法,包含它们的药物制剂及其在药物生产中的用途

摘要

The compounds have the general formula wherein R1 is the same or different and represents alkyl or alkoxy groups of 1 to 3 carbon atoms, halogen, trifluoromethyl, nitro, cyano, phenyl or alkylsulfonyl groups, n is a number from 1 to 3, and R1 is not halogen or alkyl when n is 1, X is -SO2 or -C (O) NH-, Y is - (CHR2) m -, wherein m is a number from 1 to 4 and R2 is -CH2-aryl, and Q is 10-camphoryl, -C 0 -C 0 -alkyl, aryl, -SO 2 -alkyl or -SO 2 -aryl, wherein aryl is phenyl or 4-alkyl-1,3-thiazol-5- group is substituted with 1 to 3 Z groups, with Z being -NH -C (O) -C1-6alkyl, -C (O) -C1-6alkyl or -O- (CHR3) p-OH, p is a number from 1 to 4 and R3 is H or OH, Z may represent methoxy, when the aryl group in -SO2-aryl is a phenyl group. Are obtained by ring closure of a 1-arylthiosemicarbazide derivative of the general formula wherein R1 and n are as defined in formula I by treatment with alkylene nitrite of 1 to 6 carbon atoms or alkali metal nitrite in acidic medium at a temperature of 0 to 100. The resulting salt is then converted to the corresponding free compound which subsequently reacts with a compound of the type C1SO2-YQ or O = C = NYQ, wherein Y and Q are as defined in formula I. The compounds of general formula I may form part of a pharmaceutical preparation together o with a pharmaceutically acceptable carrier or diluent. They can be used to prepare a drug for the treatment of asthma, an inhibitor drug
机译:该化合物具有通式,其中R 1相同或不同,并且表示1-3个碳原子的烷基或烷氧基,卤素,三氟甲基,硝基,氰基,苯基或烷基磺酰基,n为1-3的数,且R 1 n为1时,X为-SO2或-C(O)NH-,Y为-(CHR2)m-,其中m为1-4且R2为-CH2-芳基,且R2为卤素或烷基时, Q是10-樟脑酰基,-C 0 -C 0-烷基,芳基,-SO 2-烷基或-SO 2-芳基,其中芳基是苯基或被4-烷基-1,3-噻唑-5-基取代1至3个Z基团,Z为-NH -C(O)-C1-6烷基,-C(O)-C1-6烷基或-O-(CHR3)p-OH,p为1至4的数,并且当-SO 2-芳基中的芳基为苯基时,R 3为H或OH,Z可表示甲氧基。通过在酸性介质中于0至100的温度下用1-6个碳原子的亚烷基亚硝酸盐或碱金属亚硝酸盐处理通式为R 1和n如式I定义的通式1-芳基硫代氨基脲衍生物进行闭环反应制得然后将所得的盐转化为相应的游离化合物,其随后与C 1 SO 2 -YQ或O = C = NYQ类型的化合物反应,其中Y和Q如式I中所定义。药物制剂的一部分,以及药学上可接受的载体或稀释剂。它们可用于制备治疗哮喘的药物,抑制剂药物

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号